Sanjay Maharjan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sanjay Maharjan has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Ira Shrestha
Physiology Dept., Patan Academy of Health Sciences, Lalitpur, Nepal
2 shared publications - Jayandra Byanju
Physiology Dept., Patan Academy of Health Sciences, Lalitpur, Nepal
2 shared publications - Rakesh Kumar Jha
Department of Radiology, National Medical College and Teaching Hospital, Birgunj, Parsa, Nepal
2 shared publications - Ritu Bashyal
Patan Academy of Health Sciences, Lalitpur, Nepal
2 shared publications - Sanyukta Gurung
Patan Academy of Health Sciences, Lalitpur, Nepal
2 shared publications - Aastha Pathak1 shared publication
Latest Publications
- Open Access
- 1 July 2026
- Published by Nepal Journals Online (JOL) in Journal of Patan Academy of Health Sciences
- Vol. 13 (1) , 86-94
Perceptions and use of generative artificial intelligence among undergraduate medical and nursing students at Patan Academy of Health Sciences
Introduction: While Generative AI (GenAI) is rapidly influencing higher education, data on its integration within medical education remains limited. This study aimed to explore the perceptions, utilization patterns, and underlying concerns regarding GenAI technologies among undergraduate medical and nursing students. Method: A cross-sectional, mixed-methods descriptive study was conducted from August 2025 to March 2026 after ethical clearance from (Ref No). Total enumerative sampling targeted all enrolled MBBS and nursing cohorts. Data were collected online. The instrument featured 18 quantitative items assessing knowledge, willingness, and concerns via a 5-point Likert scale, alongside four open-ended questions evaluating uses, concerns, and integration suggestions in medical education. Quantitative data were analyzed using descriptive statistics, while qualitative responses underwent inductive thematic analysis. Result: There were 356(50.92%) respondents to the questionnaire. GenAI adoption was highly prevalent, with 300(84.27%) of students reporting “often” or “always” using the technology. Students exhibited the highest willingness toward GenAI integration, reporting agree/strongly agree, primarily to save time 290(81.46%) and access round-the-clock, 269(75.56%) personalized support. Students expressed the highest concern focused on over-reliance 183(51.41%) and the hindrance of transferable skills 172(48.32%). Qualitative results revealed that students heavily utilize AI as cognitive support to simplify complex medical concepts; they remain deeply concerned regarding intellectual laziness, cognitive decline, and AI hallucinations. Conclusion: Health sciences students leverage GenAI for academic efficiency but remain acutely aware of risks to critical thinking. Restricting the technology is unsupported by the data; rather, students advocate for proactive curriculum integration and targeted AI literacy training to ensure responsible, effective use.
- 1 July 2026
- Published by Nepal Journals Online (JOL) in Journal of Patan Academy of Health Sciences
- Vol. 13 (1) , 86-94
Open AccessPerceptions and use of generative artificial intelligence among undergraduate medical and nursing students at Patan Academy of Health Sciences
Introduction: While Generative AI (GenAI) is rapidly influencing higher education, data on its integration within medical education remains limited. This study aimed to explore the perceptions, utilization patterns, and underlying concerns regarding GenAI technologies among undergraduate medical and nursing students. Method: A cross-sectional, mixed-methods descriptive study was conducted from August 2025 to March 2026 after ethical clearance from (Ref No). Total enumerative sampling targeted all enrolled MBBS and nursing cohorts. Data were collected online. The instrument featured 18 quantitative items assessing knowledge, willingness, and concerns via a 5-point Likert scale, alongside four open-ended questions evaluating uses, concerns, and integration suggestions in medical education. Quantitative data were analyzed using descriptive statistics, while qualitative responses underwent inductive thematic analysis. Result: There were 356(50.92%) respondents to the questionnaire. GenAI adoption was highly prevalent, with 300(84.27%) of students reporting “often” or “always” using the technology. Students exhibited the highest willingness toward GenAI integration, reporting agree/strongly agree, primarily to save time 290(81.46%) and access round-the-clock, 269(75.56%) personalized support. Students expressed the highest concern focused on over-reliance 183(51.41%) and the hindrance of transferable skills 172(48.32%). Qualitative results revealed that students heavily utilize AI as cognitive support to simplify complex medical concepts; they remain deeply concerned regarding intellectual laziness, cognitive decline, and AI hallucinations. Conclusion: Health sciences students leverage GenAI for academic efficiency but remain acutely aware of risks to critical thinking. Restricting the technology is unsupported by the data; rather, students advocate for proactive curriculum integration and targeted AI literacy training to ensure responsible, effective use.
- Open Access
- 22 January 2026
- Published by Turkish Journal of Sports Medicine, Turkish Sports Medicine Association in Turkish Journal of Sports Medicine
- Vol. 61 (1) , 12-18
Impact of wearing surgical face masks on heart rate and oxygen saturation levels during the Chester Step Test exercise
Objective: Wearing a mask is recommended during COVID-19 outbreaks as a means of source control. However, controversies persist regarding wearing masks during exercise. This study aimed to assess the impact of surgical mask use on heart rate and oxygen saturation during the Chester Step Test (CST). Methods: This is a prospective crossover study involving 24 individuals (12 females and 12 males) aged 35.4 ± 3.9 years with prior ethical clearance obtained. All healthy participants underwent the CST with and without wearing the surgical mask. The CST comprised five stages, each lasting two minutes, progressively intensifying from low to vigorous levels. Measurements of heart rate, oxygen saturation using MIR Spirodoc, and perceived exertion based on the Borg Scale were obtained every two minutes throughout the exercise stages. Statistical analysis utilized the paired sample T-test and Wilcoxon signed-rank test. Results: Six females and three males couldn't complete up to stage V of the test. Wearing a surgical mask resulted in significant variations than without a mask. During CST, wearing a mask resulted in reduced oxygen saturation (mean ± SD) (94.8 ± 1.8 vs. 96.0 ± 1.9, p=0.01) in stage III, increased heart rate (123 ± 16 vs. 117 ± 14, p=0.02) in stage II, and higher perceived exertion on the Borg scale in stage II [Q2(Q1-Q3)] [8(7-9) vs. 7(7-8.8), p=0.01)], stage IV [12(10-13) vs. 11(10-12), p=0.03] and stage V [13(12-13) vs. 12(10-13), p=0.01]. Conclusion: Wearing surgical masks affected heart rate in stage II, oxygen saturation in stage III and perceived exertion in stage II, IV, and V during the Chester Step Test. These findings emphasize the potential impact of mask use on physiological responses during exercise.
- 22 January 2026
- Published by Turkish Journal of Sports Medicine, Turkish Sports Medicine Association in Turkish Journal of Sports Medicine
- Vol. 61 (1) , 12-18
Open AccessImpact of wearing surgical face masks on heart rate and oxygen saturation levels during the Chester Step Test exercise
Objective: Wearing a mask is recommended during COVID-19 outbreaks as a means of source control. However, controversies persist regarding wearing masks during exercise. This study aimed to assess the impact of surgical mask use on heart rate and oxygen saturation during the Chester Step Test (CST). Methods: This is a prospective crossover study involving 24 individuals (12 females and 12 males) aged 35.4 ± 3.9 years with prior ethical clearance obtained. All healthy participants underwent the CST with and without wearing the surgical mask. The CST comprised five stages, each lasting two minutes, progressively intensifying from low to vigorous levels. Measurements of heart rate, oxygen saturation using MIR Spirodoc, and perceived exertion based on the Borg Scale were obtained every two minutes throughout the exercise stages. Statistical analysis utilized the paired sample T-test and Wilcoxon signed-rank test. Results: Six females and three males couldn't complete up to stage V of the test. Wearing a surgical mask resulted in significant variations than without a mask. During CST, wearing a mask resulted in reduced oxygen saturation (mean ± SD) (94.8 ± 1.8 vs. 96.0 ± 1.9, p=0.01) in stage III, increased heart rate (123 ± 16 vs. 117 ± 14, p=0.02) in stage II, and higher perceived exertion on the Borg scale in stage II [Q2(Q1-Q3)] [8(7-9) vs. 7(7-8.8), p=0.01)], stage IV [12(10-13) vs. 11(10-12), p=0.03] and stage V [13(12-13) vs. 12(10-13), p=0.01]. Conclusion: Wearing surgical masks affected heart rate in stage II, oxygen saturation in stage III and perceived exertion in stage II, IV, and V during the Chester Step Test. These findings emphasize the potential impact of mask use on physiological responses during exercise.
- Open Access
- 31 December 2025
- Published by Nepal Journals Online (JOL) in Journal of Patan Academy of Health Sciences
- Vol. 12 (2) , 56-60
Study of heart rate variability test in prediabetes, prehypertension and co-existing prediabetes with prehypertension subjects
Introduction: Cardiac autonomic neuropathy is common in people with diabetes and hypertension and increases the risk of heart disease. Heart rate variability (HRV) is a reliable method to assess cardiac autonomic function. However, limited information exists about HRV changes before these conditions develop. This study aimed to assess HRV changes in individuals with prediabetes, prehypertension, and both conditions together. Method: A comparative cross-sectional study was conducted on 120 participants (both sexes, mean age 40.24±7.34 years) after ethical approval. Participants were categorized into four groups (n=30 each): control, prediabetes, prehypertension, and coexisting prediabetes with prehypertension, based on HbA1c and blood pressure measured on two occasions. HRV was recorded for 5 minutes in the sitting position using the Polar H10 device, and time- and frequency-domain parameters were analyzed and compared with controls. Result: Total Power was significantly lower in the coexisting group and prehypertensive group compared to controls (p<0.001). Time-domain indices- RMSSD, NN50, pNN50, and SDNN were also markedly reduced in the coexisting and prehypertensive groups compared to controls (p<0.001 for all). The mean RR interval was shorter in the coexisting group (p<0.001), indicating a higher resting heart rate. Maximum and minimum heart rates were also significantly higher (p = 0.032 and 0.002, respectively). HRV parameters showed no significant difference between the prediabetes and control groups. Conclusion: HRV was lowest in the coexisting group, moderately reduced in prehypertension, and unchanged in prediabetes. Coexistence of prediabetes and prehypertension causes greater autonomic dysfunction, highlighting the importance of early detection and prevention.
- 31 December 2025
- Published by Nepal Journals Online (JOL) in Journal of Patan Academy of Health Sciences
- Vol. 12 (2) , 56-60
Open AccessStudy of heart rate variability test in prediabetes, prehypertension and co-existing prediabetes with prehypertension subjects
Introduction: Cardiac autonomic neuropathy is common in people with diabetes and hypertension and increases the risk of heart disease. Heart rate variability (HRV) is a reliable method to assess cardiac autonomic function. However, limited information exists about HRV changes before these conditions develop. This study aimed to assess HRV changes in individuals with prediabetes, prehypertension, and both conditions together. Method: A comparative cross-sectional study was conducted on 120 participants (both sexes, mean age 40.24±7.34 years) after ethical approval. Participants were categorized into four groups (n=30 each): control, prediabetes, prehypertension, and coexisting prediabetes with prehypertension, based on HbA1c and blood pressure measured on two occasions. HRV was recorded for 5 minutes in the sitting position using the Polar H10 device, and time- and frequency-domain parameters were analyzed and compared with controls. Result: Total Power was significantly lower in the coexisting group and prehypertensive group compared to controls (p<0.001). Time-domain indices- RMSSD, NN50, pNN50, and SDNN were also markedly reduced in the coexisting and prehypertensive groups compared to controls (p<0.001 for all). The mean RR interval was shorter in the coexisting group (p<0.001), indicating a higher resting heart rate. Maximum and minimum heart rates were also significantly higher (p = 0.032 and 0.002, respectively). HRV parameters showed no significant difference between the prediabetes and control groups. Conclusion: HRV was lowest in the coexisting group, moderately reduced in prehypertension, and unchanged in prediabetes. Coexistence of prediabetes and prehypertension causes greater autonomic dysfunction, highlighting the importance of early detection and prevention.
- 28 September 2021
- Published by Nepal Journals Online (JOL) in Journal of Patan Academy of Health Sciences
- Vol. 8 (2) , 18-24
Adverse events following Sinopharm (Vero Cell), the inactivated COVID-19
Introduction: Various types of COVID 19 vaccine are being used globally to control the current pandemic. Post-licensure surveillance of vaccine is essential to ensure the safety. This study aimed to determine Adverse Events Following Immunization (AEFIs) of China Sinopharm (Vero cell), the inactivated COVID-19 vaccine. Method: This is a cross sectional observational study conducted at Patan hospital, Patan Academy of Health Sciences (PAHS) after the approval from IRC. Vaccine recipient between April 7 to April 13 and May 16 to May 25 were contacted through a phone call after 72 h of vaccination to record the AEFIs. Pattern and distribution of AEFIs were analyzed. Ethical approval was taken from PAHS IRC. Result: A total of 6142 individual got the first dose of the vaccine and out of them we were able to contact 4574 through phone calls. Of the 4574, only 941 were included for the follow up phone call after the second dose of the vaccine. A total of 1336 AEFIs were reported in 868(19%) first dose vaccine recipients while 147 AFEIs were reported in 105(11.2%) second dose vaccine recipients. The frequently reported AEFIs were pain at injection site, lethargy, headache, muscle ache and fever. All the AEFIs were mild to moderate in severity. Most of the AEFIs started within 24 h and resolved within 72 h. Conclusion: The Sinopharm (Vero cell) vaccine was found to have mild to moderate AEFIs in our study cohort and no case of severe AEFI was identified.
- 28 September 2021
- Published by Nepal Journals Online (JOL) in Journal of Patan Academy of Health Sciences
- Vol. 8 (2) , 18-24
Adverse events following Sinopharm (Vero Cell), the inactivated COVID-19
Introduction: Various types of COVID 19 vaccine are being used globally to control the current pandemic. Post-licensure surveillance of vaccine is essential to ensure the safety. This study aimed to determine Adverse Events Following Immunization (AEFIs) of China Sinopharm (Vero cell), the inactivated COVID-19 vaccine. Method: This is a cross sectional observational study conducted at Patan hospital, Patan Academy of Health Sciences (PAHS) after the approval from IRC. Vaccine recipient between April 7 to April 13 and May 16 to May 25 were contacted through a phone call after 72 h of vaccination to record the AEFIs. Pattern and distribution of AEFIs were analyzed. Ethical approval was taken from PAHS IRC. Result: A total of 6142 individual got the first dose of the vaccine and out of them we were able to contact 4574 through phone calls. Of the 4574, only 941 were included for the follow up phone call after the second dose of the vaccine. A total of 1336 AEFIs were reported in 868(19%) first dose vaccine recipients while 147 AFEIs were reported in 105(11.2%) second dose vaccine recipients. The frequently reported AEFIs were pain at injection site, lethargy, headache, muscle ache and fever. All the AEFIs were mild to moderate in severity. Most of the AEFIs started within 24 h and resolved within 72 h. Conclusion: The Sinopharm (Vero cell) vaccine was found to have mild to moderate AEFIs in our study cohort and no case of severe AEFI was identified.